Article
<i>In Silico</i> identification and modelling of FDA-approved drugs targeting T-type calcium channels
2024-09-29
Abstract excerpt
Studies have shown that inhibition of the Ca v 3.1 T-type calcium channel can prevent or suppress neurological diseases, such as epileptic seizures and diabetic neuropathy. In this study we aimed to use in silico simulations to identify a U.S. Food and Drug Administration (FDA)-approved drug that can bind to the Ca v 3.1 T-type calcium channel. We used the automated docking suite GOLD v5.5 with the genetic algo...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 90cfbfff-6f96-5e29-ba31-84039d8f64b9
- DOI
- 10.1101/2024.09.27.615366
